Financial toxicity is a broad term to describe the economic consequences and subjective
burden resulting from a cancer diagnosis and treatment. As financial toxicity is associated …

Hepatocellular carcinoma (HCC), particularly when accompanied by microvascular invasion
(MVI), has a markedly high risk of recurrence after liver resection. Adjuvant immunotherapy …

Cancer is a complex disease that can affect different parts of the body. The rates of cancer
have shown an increasing trend in the past decade. A majority of cancers are detected late …

Cancer treatment is associated with financial hardship for many patients and families.
Screening for financial hardship and referrals to appropriate resources for mitigation are not …

Factors at the level of family/healthcare worker, organization, and system are neglected in
medication nonadherence research in heart transplantation (HTx). The 4-continent, 11 …

Lack of adherence constitutes one of the most important challenges in patients undergoing
treatment with oral antineoplastic drugs (ANEO). Understanding cancer patients' …

Background Several epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKI)
have been approved for first‐line (1L) treatment of EGFR‐mutated metastatic non‐small cell …

BACKGROUND: Oral oncolytics are becoming increasingly common in the treatment of solid
and hematological malignancies. Medication adherence is especially important to ensure …

BACKGROUND: Various factors, including patient demographic and socioeconomic
characteristics, patient out-of-pocket (OOP) costs, therapy-related factors, clinical …

PURPOSE: We investigated the association of out-of-pocket (OOP) costs for tyrosine kinase
inhibitors (TKIs) with overall survival (OS) in epidermal growth factor receptor (EGFR)-and …